Reviparin sodium
(Redirected from Reviparin)
Reviparin sodium is a low molecular weight heparin (LMWH) that is primarily used as an anticoagulant for the prevention and treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE). It is a derivative of heparin, a naturally occurring anticoagulant produced by basophils and mast cells.
Pharmacology
Reviparin sodium works by enhancing the inhibition of Factor Xa and thrombin by increasing antithrombin III activity. This prevents the conversion of fibrinogen to fibrin, thereby inhibiting blood clot formation. It has a higher ratio of anti-Factor Xa to anti-thrombin activity compared to unfractionated heparin, which may contribute to its superior efficacy and safety profile.
Clinical Use
Reviparin sodium is indicated for the prevention of DVT and PE in patients undergoing orthopedic or abdominal surgery, and in acutely ill medical patients at risk for thromboembolic complications. It is also used for the treatment of acute DVT and PE, and for the prevention of clotting in the extracorporeal circulation during hemodialysis.
Side Effects
The most common side effect of reviparin sodium is bleeding. Other side effects may include thrombocytopenia, hypersensitivity reactions, and, rarely, osteoporosis with long-term use.
Contraindications
Reviparin sodium is contraindicated in patients with active major bleeding, severe thrombocytopenia, or known hypersensitivity to reviparin sodium or to any of its components. It should be used with caution in patients with a high risk of bleeding, such as those with severe hypertension, peptic ulcer disease, or recent brain, spinal, or ophthalmic surgery.
Dosage and Administration
The dosage of reviparin sodium is individualized based on the patient's weight, indication, and renal function. It is administered subcutaneously, usually once or twice daily.
See Also
- Low molecular weight heparin
- Anticoagulant
- Deep vein thrombosis
- Pulmonary embolism
- Heparin
- Factor Xa
- Thrombin
- Fibrin
- Hemodialysis
- Thrombocytopenia
- Osteoporosis
Reviparin_sodium
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD